Filing Details
- Accession Number:
- 0001144204-15-067473
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-23 14:56:05
- Reporting Period:
- 2015-11-20
- Filing Date:
- 2015-11-23
- Accepted Time:
- 2015-11-23 14:56:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293310 | Kalobios Pharmaceuticals Inc | KBIO | Pharmaceutical Preparations (2834) | 770557236 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1525354 | Martin Shkreli | C/O Turing Pharmaceuticals Llc 1177 Avenue Of The Americas, 39Th Floor New York NY 10036 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-11-20 | 5,000 | $18.88 | 2,070,200 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The securities reported herein are owned directly by Martin Shkreli, who is a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934. There is no voting or ownership agreement amongst the group members and the other members of the group do not have a pecuniary interest in the shares reported herein. Correspondingly, Mr. Shkreli does not have a pecuniary interest in the shares owned by the other members of the group.
Billionaire Hedge Funds
